echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > From January to August, the overall supply of centralized procurement of coronary stents is sufficient

    From January to August, the overall supply of centralized procurement of coronary stents is sufficient

    • Last Update: 2021-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 6, the National Organization for the Joint Procurement Office of High-Value Medical Consumables (hereinafter referred to as the Joint Procurement Office) disclosed the implementation of the results of the centralized procurement of coronary stents since January 2021
    .
    From January to August, medical institutions used a total of 1.
    1 million selected products.
    After deducting the amount used by medical institutions, the supply of selected companies reached 880,000 in circulation and inventory
    .
    The overall supply of selected coronary stents is stable, and the overall supply of various types of stents exceeds the procurement demand
    .
     
    According to the information disclosed by the United Procurement Office, from January to August this year, the total amount of selected products used by medical institutions has exceeded the national annual agreement purchase volume (1.
    07 million); the selected enterprises have delivered 1.
    98 million selected stents, reaching the annual agreement More than 1.
    8 times the purchase volume, and the overall supply is sufficient
    .
     
    The centralized procurement of coronary stents is the first order organized by the state for the centralized procurement of high-value medical consumables
    .
    The United Procurement Office stated that the reform of centralized procurement of coronary stents has achieved obvious results, the people have benefited significantly, and the industrial development environment has been optimized
    .
    The disclosure shows that the price of selected products in centralized procurement has dropped significantly.
    According to Beijing's calculations, the average personal burden of patients receiving stent implantation has dropped by 10,000 yuan
    .
    In addition, a total of 11 companies participated in the bidding in this centralized procurement, and 8 companies were selected to obtain 80% of the market share, which increased the industry concentration
    .
     
    Centralized sourcing has changed the original circulation mode, and requires the strengthening of cooperation between production, distribution, and use parties, changing the habits formed in the past, and adapting to the new mechanism
    .
    Some problems were also exposed during the running-in process of all parties
    .
    The United Procurement Office pointed out that at present, the production, distribution and users are still in the process of adapting to the changes in the centralized procurement mode, and the connection of the relevant parties in the supply chain is still adapting to each other, which has also caused a temporary shortage of individual models of brackets
    .
    In addition, the rapid increase in the use of high-priced drug balloons in some hospitals is not only due to a reasonable increase in clinical development, but also caused by other abnormal factors
    .
     
      The United Procurement Office stated that it will closely monitor the procurement, distribution and use of the selected products with the provincial procurement agencies, and require the selected companies to strictly perform contracts, adapt to demand, adjust production capacity, and compact the company’s supply and distribution responsibilities; and coordinate with relevant departments to guide medical institutions to strengthen Build procurement and inventory management capabilities, improve the efficiency of information transmission and procurement operations, standardize the use of drug balloons, and promote the local development of centralized drug balloon procurement
    .
      On September 6, the National Organization for the Joint Procurement Office of High-Value Medical Consumables (hereinafter referred to as the Joint Procurement Office) disclosed the implementation of the results of the centralized procurement of coronary stents since January 2021
    .
    From January to August, medical institutions used a total of 1.
    1 million selected products.
    After deducting the amount used by medical institutions, the supply of selected companies reached 880,000 in circulation and inventory
    .
    The overall supply of selected coronary stents is stable, and the overall supply of various types of stents exceeds the procurement demand
    .
     
      According to the information disclosed by the United Procurement Office, from January to August this year, the total amount of selected products used by medical institutions has exceeded the national annual agreement purchase volume (1.
    07 million); the selected enterprises have delivered 1.
    98 million selected stents, reaching the annual agreement More than 1.
    8 times the purchase volume, and the overall supply is sufficient
    .
     
      The centralized procurement of coronary stents is the first order organized by the state for the centralized procurement of high-value medical consumables
    .
    The United Procurement Office stated that the reform of centralized procurement of coronary stents has achieved obvious results, the people have benefited significantly, and the industrial development environment has been optimized
    .
    The disclosure shows that the price of selected products in centralized procurement has dropped significantly.
    According to Beijing's calculations, the average personal burden of patients receiving stent implantation has dropped by 10,000 yuan
    .
    In addition, a total of 11 companies participated in the bidding in this centralized procurement, and 8 companies were selected to obtain 80% of the market share, which increased the industry concentration
    .
     
      Centralized sourcing has changed the original circulation mode, and requires the strengthening of cooperation between production, distribution, and use parties, changing the habits formed in the past, and adapting to the new mechanism
    .
    Some problems were also exposed during the running-in process of all parties
    .
    The United Procurement Office pointed out that at present, the production, distribution and users are still in the process of adapting to the changes in the centralized procurement mode, and the connection of the relevant parties in the supply chain is still adapting to each other, which has also caused a temporary shortage of individual models of brackets
    .
    In addition, the rapid increase in the use of high-priced drug balloons in some hospitals is not only due to a reasonable increase in clinical development, but also caused by other abnormal factors
    .
     
      The United Procurement Office stated that it will closely monitor the procurement, distribution and use of the selected products with the provincial procurement agencies, and require the selected companies to strictly perform contracts, adapt to demand, adjust production capacity, and compact the company’s supply and distribution responsibilities; and coordinate with relevant departments to guide medical institutions to strengthen Build procurement and inventory management capabilities, improve the efficiency of information transmission and procurement operations, standardize the use of drug balloons, and promote the local development of centralized drug balloon procurement
    .
      On September 6, the National Organization for the Joint Procurement Office of High-Value Medical Consumables (hereinafter referred to as the Joint Procurement Office) disclosed the implementation of the results of the centralized procurement of coronary stents since January 2021
    .
    From January to August, medical institutions used a total of 1.
    1 million selected products.
    After deducting the amount used by medical institutions, the supply of selected companies reached 880,000 in circulation and inventory
    .
    The overall supply of selected coronary stents is stable, and the overall supply of various types of stents exceeds the procurement demand
    .
     
      According to the information disclosed by the United Procurement Office, from January to August this year, the total amount of selected products used by medical institutions has exceeded the national annual agreement purchase volume (1.
    07 million); the selected enterprises have delivered 1.
    98 million selected stents, reaching the annual agreement More than 1.
    8 times the purchase volume, and the overall supply is sufficient
    .
    Enterprise business enterprise
     
      The centralized procurement of coronary stents is the first order organized by the state for the centralized procurement of high-value medical consumables
    .
    The United Procurement Office stated that the reform of centralized procurement of coronary stents has achieved obvious results, the people have benefited significantly, and the industrial development environment has been optimized
    .
    The disclosure shows that the price of selected products in centralized procurement has dropped significantly.
    According to Beijing's calculations, the average personal burden of patients receiving stent implantation has dropped by 10,000 yuan
    .
    In addition, a total of 11 companies participated in the bidding in this centralized procurement, and 8 companies were selected to obtain 80% of the market share, which increased the industry concentration
    .
     
      Centralized sourcing has changed the original circulation mode, and requires the strengthening of cooperation between production, distribution, and use parties, changing the habits formed in the past, and adapting to the new mechanism
    .
    Some problems were also exposed during the running-in process of all parties
    .
    The United Procurement Office pointed out that at present, the production, distribution and users are still in the process of adapting to the changes in the centralized procurement mode, and the connection of the relevant parties in the supply chain is still adapting to each other, which has also caused a temporary shortage of individual models of brackets
    .
    In addition, the rapid increase in the use of high-priced drug balloons in some hospitals is not only due to a reasonable increase in clinical development, but also caused by other abnormal factors
    .
    Hospital hospital hospital
     
      The United Procurement Office stated that it will closely monitor the procurement, distribution and use of the selected products with the provincial procurement agencies, and require the selected companies to strictly perform contracts, adapt to demand, adjust production capacity, and compact the company’s supply and distribution responsibilities; and coordinate with relevant departments to guide medical institutions to strengthen Build procurement and inventory management capabilities, improve the efficiency of information transmission and procurement operations, standardize the use of drug balloons, and promote the local development of centralized drug balloon procurement
    .
    Procurement Procurement Procurement
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.